Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC "Pharmcenter VILAR", Russia)

Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC "Pharmcenter VILAR", Russia)

Introduction. Allaforte® (JSC "Pharmcenter VILAR", Russia) is an antiarrhythmic long-acting drug. The dosage form of the drug Allaforte® provides a decrease in the frequency of taking the drug and also reduces the risk of side effects. It is relevant when taking antiarrhythmic drugs of the...

Full description

Bibliographic Details
Main Authors: O. A. Archakova, N. S. Bagaeva, T. N. Komarov, A. V. Rogov, D. S. Shchelgacheva, A. V. Suvorova, P. K. Karnakova, P. A. Karpova, I. E. Shohin
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2022-02-01
Series:Разработка и регистрация лекарственных средств
Subjects:
lappaconitine
n-desacetyllappaconitine
allaforte®
plasma
pharmacokinetics
arrhythmya
Online Access:https://www.pharmjournal.ru/jour/article/view/1172

Internet

https://www.pharmjournal.ru/jour/article/view/1172

Similar Items